NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

細胞信號傳達的全球市場

Cell Signaling

出版商 Global Industry Analysts, Inc. 商品編碼 898204
出版日期 內容資訊 英文 218 Pages
商品交期: 最快1-2個工作天內
價格
細胞信號傳達的全球市場 Cell Signaling
出版日期: 2021年04月01日內容資訊: 英文 218 Pages
簡介

本報告提供全球細胞信號傳達 (細胞信號) 市場相關分析,彙整整體市場規模的實際成果值·預測值,及主要推動及阻礙市場要素,各用途·各產品種類·各技術及各企業的市場佔有率趨勢 (今後8年份),今後的市場成長的方向性,各地區·主要國家的市場詳細趨勢等調查,主要企業的簡介等資訊,為您概述為以下內容。

第1章 分析方法

第2章 摘要整理

  • 市場概要
    • 各企業的市場佔有率結構 (最新值·預測值)
    • 各市場區隔的市場佔有率結構 (最新值·預測值)
  • 代表性企業分析
  • 市場趨勢與促進因素
  • 全球市場的未來展望
    • 市場規模·佔有率趨勢預測:各地區/各國
    • 各用途 (研究,醫療)
    • 各類型 (內分泌/旁分泌/自分泌/接觸分泌等)
    • 各產品種類 (消耗品,設備)
    • 各技術 (顯微鏡,西方印漬術,流式細胞技術,免疫組織化學 (IHC),ELISA,質譜分析等)

第3章 市場分析

  • 各地區的市場分析
  • 美國
    • 市場基本資料
    • 各企業市場佔有率
    • 細胞信號傳達的市場規模 (實際成果值·預測值)
    • 各用途的市場規模 (實際成果值·預測值)
    • 各產品種類的市場規模 (實際成果值·預測值)
    • 各技術的市場規模 (實際成果值·預測值)
  • 加拿大
  • 日本
  • 中國
  • 歐洲 (法國,德國,義大利,英國等)
  • 亞太地區
  • 其他的國家 (RoW)

第4章 企業

  • BECKMAN COULTER
  • BIO-RAD LABORATORIES
  • BIO-TECHNE CORPORATION
  • MERCK KGAA
  • PERKINELMER
  • PROMEGA CORPORATION
  • QIAGEN NV
  • THERMO FISHER SCIENTIFIC

第5章 相關分析

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP10950

Abstract:

Global Cell Signaling Market to Reach $4 Billion by 2027

Amid the COVID-19 crisis, the global market for Cell Signaling estimated at US$2.8 Billion in the year 2020, is projected to reach a revised size of US$4 Billion by 2027, growing at a CAGR of 5.4% over the analysis period 2020-2027. Endocrine Signaling, one of the segments analyzed in the report, is projected to record a 5.8% CAGR and reach US$1.5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Paracrine Signaling segment is readjusted to a revised 5.6% CAGR for the next 7-year period.

The U.S. Market is Estimated at $826.1 Million, While China is Forecast to Grow at 5% CAGR

The Cell Signaling market in the U.S. is estimated at US$826.1 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$713.1 Million by the year 2027 trailing a CAGR of 5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.2% and 4.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.

Autocrine Signaling Segment to Record 4.9% CAGR

In the global Autocrine Signaling segment, USA, Canada, Japan, China and Europe will drive the 4.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$384.1 Million in the year 2020 will reach a projected size of US$538.1 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$464.4 Million by the year 2027.

Select Competitors (Total 46 Featured) -

  • Beckman Coulter, Inc.
  • Becton, Dickinson & Company
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Coporation
  • Merck KgaA
  • PerkinElmer, Inc.
  • Promega Corporation
  • Qiagen NV
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Cell Signaling by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 2: World 7-Year Perspective for Cell Signaling by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027
    • TABLE 3: World Current & Future Analysis for Endocrine Signaling by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 4: World 7-Year Perspective for Endocrine Signaling by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 5: World Current & Future Analysis for Paracrine Signaling by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 6: World 7-Year Perspective for Paracrine Signaling by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Autocrine Signaling by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 8: World 7-Year Perspective for Autocrine Signaling by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 9: World Current & Future Analysis for Juxtacrine Signaling by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 10: World 7-Year Perspective for Juxtacrine Signaling by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 11: World Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 12: World 7-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 14: World 7-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 15: World Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 16: World 7-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 17: World Current & Future Analysis for Microscopy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 18: World 7-Year Perspective for Microscopy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 19: World Current & Future Analysis for Western Blotting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 20: World 7-Year Perspective for Western Blotting by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 21: World Current & Future Analysis for Flow Cytometry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 22: World 7-Year Perspective for Flow Cytometry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 23: World Current & Future Analysis for Immunohistochemistry (IHC) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 24: World 7-Year Perspective for Immunohistochemistry (IHC) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 25: World Current & Future Analysis for ELISA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 26: World 7-Year Perspective for ELISA by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 27: World Current & Future Analysis for Mass Spectrometry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 28: World 7-Year Perspective for Mass Spectrometry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 29: World Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 30: World 7-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 31: World Current & Future Analysis for Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 32: World 7-Year Perspective for Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 33: World Current & Future Analysis for Medical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 34: World 7-Year Perspective for Medical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 35: USA Current & Future Analysis for Cell Signaling by Type - Endocrine Signaling, Paracrine Signaling, Autocrine Signaling, Juxtacrine Signaling and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 36: USA 7-Year Perspective for Cell Signaling by Type - Percentage Breakdown of Value Sales for Endocrine Signaling, Paracrine Signaling, Autocrine Signaling, Juxtacrine Signaling and Other Types for the Years 2020 & 2027
    • TABLE 37: USA Current & Future Analysis for Cell Signaling by Product Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 38: USA 7-Year Perspective for Cell Signaling by Product Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2020 & 2027
    • TABLE 39: USA Current & Future Analysis for Cell Signaling by Technology - Microscopy, Western Blotting, Flow Cytometry, Immunohistochemistry (IHC), ELISA, Mass Spectrometry and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 40: USA 7-Year Perspective for Cell Signaling by Technology - Percentage Breakdown of Value Sales for Microscopy, Western Blotting, Flow Cytometry, Immunohistochemistry (IHC), ELISA, Mass Spectrometry and Other Technologies for the Years 2020 & 2027
    • TABLE 41: USA Current & Future Analysis for Cell Signaling by Application - Research and Medical - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 42: USA 7-Year Perspective for Cell Signaling by Application - Percentage Breakdown of Value Sales for Research and Medical for the Years 2020 & 2027
  • CANADA
    • TABLE 43: Canada Current & Future Analysis for Cell Signaling by Type - Endocrine Signaling, Paracrine Signaling, Autocrine Signaling, Juxtacrine Signaling and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 44: Canada 7-Year Perspective for Cell Signaling by Type - Percentage Breakdown of Value Sales for Endocrine Signaling, Paracrine Signaling, Autocrine Signaling, Juxtacrine Signaling and Other Types for the Years 2020 & 2027
    • TABLE 45: Canada Current & Future Analysis for Cell Signaling by Product Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 46: Canada 7-Year Perspective for Cell Signaling by Product Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2020 & 2027
    • TABLE 47: Canada Current & Future Analysis for Cell Signaling by Technology - Microscopy, Western Blotting, Flow Cytometry, Immunohistochemistry (IHC), ELISA, Mass Spectrometry and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 48: Canada 7-Year Perspective for Cell Signaling by Technology - Percentage Breakdown of Value Sales for Microscopy, Western Blotting, Flow Cytometry, Immunohistochemistry (IHC), ELISA, Mass Spectrometry and Other Technologies for the Years 2020 & 2027
    • TABLE 49: Canada Current & Future Analysis for Cell Signaling by Application - Research and Medical - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 50: Canada 7-Year Perspective for Cell Signaling by Application - Percentage Breakdown of Value Sales for Research and Medical for the Years 2020 & 2027
  • JAPAN
    • TABLE 51: Japan Current & Future Analysis for Cell Signaling by Type - Endocrine Signaling, Paracrine Signaling, Autocrine Signaling, Juxtacrine Signaling and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 52: Japan 7-Year Perspective for Cell Signaling by Type - Percentage Breakdown of Value Sales for Endocrine Signaling, Paracrine Signaling, Autocrine Signaling, Juxtacrine Signaling and Other Types for the Years 2020 & 2027
    • TABLE 53: Japan Current & Future Analysis for Cell Signaling by Product Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 54: Japan 7-Year Perspective for Cell Signaling by Product Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2020 & 2027
    • TABLE 55: Japan Current & Future Analysis for Cell Signaling by Technology - Microscopy, Western Blotting, Flow Cytometry, Immunohistochemistry (IHC), ELISA, Mass Spectrometry and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 56: Japan 7-Year Perspective for Cell Signaling by Technology - Percentage Breakdown of Value Sales for Microscopy, Western Blotting, Flow Cytometry, Immunohistochemistry (IHC), ELISA, Mass Spectrometry and Other Technologies for the Years 2020 & 2027
    • TABLE 57: Japan Current & Future Analysis for Cell Signaling by Application - Research and Medical - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 58: Japan 7-Year Perspective for Cell Signaling by Application - Percentage Breakdown of Value Sales for Research and Medical for the Years 2020 & 2027
  • CHINA
    • TABLE 59: China Current & Future Analysis for Cell Signaling by Type - Endocrine Signaling, Paracrine Signaling, Autocrine Signaling, Juxtacrine Signaling and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 60: China 7-Year Perspective for Cell Signaling by Type - Percentage Breakdown of Value Sales for Endocrine Signaling, Paracrine Signaling, Autocrine Signaling, Juxtacrine Signaling and Other Types for the Years 2020 & 2027
    • TABLE 61: China Current & Future Analysis for Cell Signaling by Product Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 62: China 7-Year Perspective for Cell Signaling by Product Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2020 & 2027
    • TABLE 63: China Current & Future Analysis for Cell Signaling by Technology - Microscopy, Western Blotting, Flow Cytometry, Immunohistochemistry (IHC), ELISA, Mass Spectrometry and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 64: China 7-Year Perspective for Cell Signaling by Technology - Percentage Breakdown of Value Sales for Microscopy, Western Blotting, Flow Cytometry, Immunohistochemistry (IHC), ELISA, Mass Spectrometry and Other Technologies for the Years 2020 & 2027
    • TABLE 65: China Current & Future Analysis for Cell Signaling by Application - Research and Medical - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 66: China 7-Year Perspective for Cell Signaling by Application - Percentage Breakdown of Value Sales for Research and Medical for the Years 2020 & 2027
  • EUROPE
    • TABLE 67: Europe Current & Future Analysis for Cell Signaling by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 68: Europe 7-Year Perspective for Cell Signaling by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027
    • TABLE 69: Europe Current & Future Analysis for Cell Signaling by Type - Endocrine Signaling, Paracrine Signaling, Autocrine Signaling, Juxtacrine Signaling and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 70: Europe 7-Year Perspective for Cell Signaling by Type - Percentage Breakdown of Value Sales for Endocrine Signaling, Paracrine Signaling, Autocrine Signaling, Juxtacrine Signaling and Other Types for the Years 2020 & 2027
    • TABLE 71: Europe Current & Future Analysis for Cell Signaling by Product Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 72: Europe 7-Year Perspective for Cell Signaling by Product Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2020 & 2027
    • TABLE 73: Europe Current & Future Analysis for Cell Signaling by Technology - Microscopy, Western Blotting, Flow Cytometry, Immunohistochemistry (IHC), ELISA, Mass Spectrometry and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 74: Europe 7-Year Perspective for Cell Signaling by Technology - Percentage Breakdown of Value Sales for Microscopy, Western Blotting, Flow Cytometry, Immunohistochemistry (IHC), ELISA, Mass Spectrometry and Other Technologies for the Years 2020 & 2027
    • TABLE 75: Europe Current & Future Analysis for Cell Signaling by Application - Research and Medical - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 76: Europe 7-Year Perspective for Cell Signaling by Application - Percentage Breakdown of Value Sales for Research and Medical for the Years 2020 & 2027
  • FRANCE
    • TABLE 77: France Current & Future Analysis for Cell Signaling by Type - Endocrine Signaling, Paracrine Signaling, Autocrine Signaling, Juxtacrine Signaling and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 78: France 7-Year Perspective for Cell Signaling by Type - Percentage Breakdown of Value Sales for Endocrine Signaling, Paracrine Signaling, Autocrine Signaling, Juxtacrine Signaling and Other Types for the Years 2020 & 2027
    • TABLE 79: France Current & Future Analysis for Cell Signaling by Product Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 80: France 7-Year Perspective for Cell Signaling by Product Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2020 & 2027
    • TABLE 81: France Current & Future Analysis for Cell Signaling by Technology - Microscopy, Western Blotting, Flow Cytometry, Immunohistochemistry (IHC), ELISA, Mass Spectrometry and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 82: France 7-Year Perspective for Cell Signaling by Technology - Percentage Breakdown of Value Sales for Microscopy, Western Blotting, Flow Cytometry, Immunohistochemistry (IHC), ELISA, Mass Spectrometry and Other Technologies for the Years 2020 & 2027
    • TABLE 83: France Current & Future Analysis for Cell Signaling by Application - Research and Medical - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 84: France 7-Year Perspective for Cell Signaling by Application - Percentage Breakdown of Value Sales for Research and Medical for the Years 2020 & 2027
  • GERMANY
    • TABLE 85: Germany Current & Future Analysis for Cell Signaling by Type - Endocrine Signaling, Paracrine Signaling, Autocrine Signaling, Juxtacrine Signaling and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 86: Germany 7-Year Perspective for Cell Signaling by Type - Percentage Breakdown of Value Sales for Endocrine Signaling, Paracrine Signaling, Autocrine Signaling, Juxtacrine Signaling and Other Types for the Years 2020 & 2027
    • TABLE 87: Germany Current & Future Analysis for Cell Signaling by Product Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 88: Germany 7-Year Perspective for Cell Signaling by Product Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2020 & 2027
    • TABLE 89: Germany Current & Future Analysis for Cell Signaling by Technology - Microscopy, Western Blotting, Flow Cytometry, Immunohistochemistry (IHC), ELISA, Mass Spectrometry and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 90: Germany 7-Year Perspective for Cell Signaling by Technology - Percentage Breakdown of Value Sales for Microscopy, Western Blotting, Flow Cytometry, Immunohistochemistry (IHC), ELISA, Mass Spectrometry and Other Technologies for the Years 2020 & 2027
    • TABLE 91: Germany Current & Future Analysis for Cell Signaling by Application - Research and Medical - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 92: Germany 7-Year Perspective for Cell Signaling by Application - Percentage Breakdown of Value Sales for Research and Medical for the Years 2020 & 2027
  • ITALY
    • TABLE 93: Italy Current & Future Analysis for Cell Signaling by Type - Endocrine Signaling, Paracrine Signaling, Autocrine Signaling, Juxtacrine Signaling and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 94: Italy 7-Year Perspective for Cell Signaling by Type - Percentage Breakdown of Value Sales for Endocrine Signaling, Paracrine Signaling, Autocrine Signaling, Juxtacrine Signaling and Other Types for the Years 2020 & 2027
    • TABLE 95: Italy Current & Future Analysis for Cell Signaling by Product Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 96: Italy 7-Year Perspective for Cell Signaling by Product Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2020 & 2027
    • TABLE 97: Italy Current & Future Analysis for Cell Signaling by Technology - Microscopy, Western Blotting, Flow Cytometry, Immunohistochemistry (IHC), ELISA, Mass Spectrometry and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 98: Italy 7-Year Perspective for Cell Signaling by Technology - Percentage Breakdown of Value Sales for Microscopy, Western Blotting, Flow Cytometry, Immunohistochemistry (IHC), ELISA, Mass Spectrometry and Other Technologies for the Years 2020 & 2027
    • TABLE 99: Italy Current & Future Analysis for Cell Signaling by Application - Research and Medical - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 100: Italy 7-Year Perspective for Cell Signaling by Application - Percentage Breakdown of Value Sales for Research and Medical for the Years 2020 & 2027
  • UNITED KINGDOM
    • TABLE 101: UK Current & Future Analysis for Cell Signaling by Type - Endocrine Signaling, Paracrine Signaling, Autocrine Signaling, Juxtacrine Signaling and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 102: UK 7-Year Perspective for Cell Signaling by Type - Percentage Breakdown of Value Sales for Endocrine Signaling, Paracrine Signaling, Autocrine Signaling, Juxtacrine Signaling and Other Types for the Years 2020 & 2027
    • TABLE 103: UK Current & Future Analysis for Cell Signaling by Product Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 104: UK 7-Year Perspective for Cell Signaling by Product Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2020 & 2027
    • TABLE 105: UK Current & Future Analysis for Cell Signaling by Technology - Microscopy, Western Blotting, Flow Cytometry, Immunohistochemistry (IHC), ELISA, Mass Spectrometry and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 106: UK 7-Year Perspective for Cell Signaling by Technology - Percentage Breakdown of Value Sales for Microscopy, Western Blotting, Flow Cytometry, Immunohistochemistry (IHC), ELISA, Mass Spectrometry and Other Technologies for the Years 2020 & 2027
    • TABLE 107: UK Current & Future Analysis for Cell Signaling by Application - Research and Medical - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 108: UK 7-Year Perspective for Cell Signaling by Application - Percentage Breakdown of Value Sales for Research and Medical for the Years 2020 & 2027
  • REST OF EUROPE
    • TABLE 109: Rest of Europe Current & Future Analysis for Cell Signaling by Type - Endocrine Signaling, Paracrine Signaling, Autocrine Signaling, Juxtacrine Signaling and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 110: Rest of Europe 7-Year Perspective for Cell Signaling by Type - Percentage Breakdown of Value Sales for Endocrine Signaling, Paracrine Signaling, Autocrine Signaling, Juxtacrine Signaling and Other Types for the Years 2020 & 2027
    • TABLE 111: Rest of Europe Current & Future Analysis for Cell Signaling by Product Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 112: Rest of Europe 7-Year Perspective for Cell Signaling by Product Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2020 & 2027
    • TABLE 113: Rest of Europe Current & Future Analysis for Cell Signaling by Technology - Microscopy, Western Blotting, Flow Cytometry, Immunohistochemistry (IHC), ELISA, Mass Spectrometry and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 114: Rest of Europe 7-Year Perspective for Cell Signaling by Technology - Percentage Breakdown of Value Sales for Microscopy, Western Blotting, Flow Cytometry, Immunohistochemistry (IHC), ELISA, Mass Spectrometry and Other Technologies for the Years 2020 & 2027
    • TABLE 115: Rest of Europe Current & Future Analysis for Cell Signaling by Application - Research and Medical - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 116: Rest of Europe 7-Year Perspective for Cell Signaling by Application - Percentage Breakdown of Value Sales for Research and Medical for the Years 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 117: Asia-Pacific Current & Future Analysis for Cell Signaling by Type - Endocrine Signaling, Paracrine Signaling, Autocrine Signaling, Juxtacrine Signaling and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 118: Asia-Pacific 7-Year Perspective for Cell Signaling by Type - Percentage Breakdown of Value Sales for Endocrine Signaling, Paracrine Signaling, Autocrine Signaling, Juxtacrine Signaling and Other Types for the Years 2020 & 2027
    • TABLE 119: Asia-Pacific Current & Future Analysis for Cell Signaling by Product Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 120: Asia-Pacific 7-Year Perspective for Cell Signaling by Product Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2020 & 2027
    • TABLE 121: Asia-Pacific Current & Future Analysis for Cell Signaling by Technology - Microscopy, Western Blotting, Flow Cytometry, Immunohistochemistry (IHC), ELISA, Mass Spectrometry and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 122: Asia-Pacific 7-Year Perspective for Cell Signaling by Technology - Percentage Breakdown of Value Sales for Microscopy, Western Blotting, Flow Cytometry, Immunohistochemistry (IHC), ELISA, Mass Spectrometry and Other Technologies for the Years 2020 & 2027
    • TABLE 123: Asia-Pacific Current & Future Analysis for Cell Signaling by Application - Research and Medical - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 124: Asia-Pacific 7-Year Perspective for Cell Signaling by Application - Percentage Breakdown of Value Sales for Research and Medical for the Years 2020 & 2027
  • REST OF WORLD
    • TABLE 125: Rest of World Current & Future Analysis for Cell Signaling by Type - Endocrine Signaling, Paracrine Signaling, Autocrine Signaling, Juxtacrine Signaling and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 126: Rest of World 7-Year Perspective for Cell Signaling by Type - Percentage Breakdown of Value Sales for Endocrine Signaling, Paracrine Signaling, Autocrine Signaling, Juxtacrine Signaling and Other Types for the Years 2020 & 2027
    • TABLE 127: Rest of World Current & Future Analysis for Cell Signaling by Product Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 128: Rest of World 7-Year Perspective for Cell Signaling by Product Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2020 & 2027
    • TABLE 129: Rest of World Current & Future Analysis for Cell Signaling by Technology - Microscopy, Western Blotting, Flow Cytometry, Immunohistochemistry (IHC), ELISA, Mass Spectrometry and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 130: Rest of World 7-Year Perspective for Cell Signaling by Technology - Percentage Breakdown of Value Sales for Microscopy, Western Blotting, Flow Cytometry, Immunohistochemistry (IHC), ELISA, Mass Spectrometry and Other Technologies for the Years 2020 & 2027
    • TABLE 131: Rest of World Current & Future Analysis for Cell Signaling by Application - Research and Medical - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 132: Rest of World 7-Year Perspective for Cell Signaling by Application - Percentage Breakdown of Value Sales for Research and Medical for the Years 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 46